Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
Philips is introducing its IntelliVue X3 patient monitoring system in Europe. The device is designed to monitor vitals at the bedside and when patients are being moved between locations to cut the ...
Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Health systems strive to deliver consistent quality ...
New technology integrates seamlessly into IntelliVue Patient Monitoring system to deliver real-time data records and enhance clinical decision support Royal Philips, a global health technology company ...
More than a year after doling out an emergency use authorization for a handful of Philips’ IntelliVue patient monitoring devices, the FDA is doubling down on the regulatory nod. Two of the patient ...
Medasense Biometrics Ltd., developer of the physiological pain-response monitoring technology (NOL® ‒- the Nociception Level Index), now supports Philips IntelliVue Patient Monitors for anesthesia and ...
Philips Healthcare has announced that its IntelliVue monitors collect, combine and cross-reference physiologic data to provide a coherent picture of patient status. And now, Philips has now obtained ...
Dutch health tech giant Royal Philips has scored FDA 510(k) clearance for its IntelliVue MX750 and MX850 patient monitors. The monitors, which received an FDA emergency use authorization in 2020 and ...
When it comes to peripheral intravenous (IV) therapy, doctors and nurses have come to accept that things might not go smoothly. Nearly 80% of hospital patients in the U.S. receive an IV — a procedure ...
Medasense Biometrics Ltd, a developer of the physiological pain-response monitoring technology (NOL ?- the Nociception Level Index), now supports Philips IntelliVue Patient Monitors for anaesthesia ...
A year after they were given an emergency nod to be used during the pandemic, two of Royal Philips’ newest patient monitors now are cleared by the Food and Drug Administration. The agency recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback